FDA Increases OTC Monograph User Fees by 19 Percent for Fiscal 2022 Post author:PacConAdmin Post published:March 14, 2022 Post category:Drug Industry Daily The FDA has released its over-the-counter (OTC) monograph drug user fees for fiscal 2022. Source: Drug Industry Daily You Might Also Like Lilly Settles Cialis Patent Case, Delaying Generic Competition Through September 2018 July 14, 2017 Semiannual Agenda Flags Upcoming FDA Regulatory Actions June 8, 2018 Federal Judge Dismisses Many Cases Alleging Harm From Merck’s Shingles Vaccine December 11, 2022